Home Capital Market China Artificial Intelligence Drug Research Firm QuantumPharm XtalPi IPO in Hong Kong...

China Artificial Intelligence Drug Research Firm QuantumPharm XtalPi IPO in Hong Kong at $2.3 Billion Market Value & Raised $127 Million, IPO Price at HKD 5.28 with Share Price Increasing +9.8% to HKD 5.8 on Day 1 of Trading, First Hong Kong Exchange IPO under Chapter 18C Allowing IPO for Pre-Revenue Technology Firms with at Least HKD 10 Billion Market Value Equivalent to $1.2 Billion

Jun 13, 2024

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Caproasia - Learn more

2024 / 2025 Summits in Hong Kong & Singapore
Institutional Investor Summit / Roundtable - March / Oct / Nov
Investment / Alternatives Summit - March / Oct / Nov
Investment Day - March / July / Sept / Oct / Nov
Private Wealth Summit - April / Oct / Nov
Family Office Summit - April / Oct / Nov
View Events | Register

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $30 billion.

China Artificial Intelligence Drug Research Firm QuantumPharm XtalPi IPO in Hong Kong at $2.3 Billion Market Value & Raised $127 Million, IPO Price at HKD 5.28 with Share Price Increasing +9.8% to HKD 5.8 on Day 1 of Trading, First Hong Kong Exchange IPO under Chapter 18C Allowing IPO for Pre-Revenue Technology Firms with at Least HKD 10 Billion Market Value Equivalent to $1.2 Billion

13th June 2024 | Hong Kong

China artificial intelligence (AI) drug research firm QuantumPharm (XtalPi) has IPO on Hong Kong Exchange (HKEX, 13/6/24) at $2.3 billion market value (HKD 11.7 billion) and raised $127 million in the IPO, with IPO price at HKD 5.28 and share price increasing +9.8% to HKD 5.8 on day 1 of trading. QuantumPharm XtalPi is the first Hong Kong Exchange IPO under the new Chapter 18C regime, allowing IPO for pre-revenue technology firms with at least HKD 10 billion market value ($1.2 billion). QuantumPharm (XtalPi) key investors include Tencent, HongShan, China Life Insurance, SoftBank & Google. QuantumPharm (XtalPi) IPO cornerstone investor includes Chairman of Henderson Land Development Peter Lee Ka-kit, via his investment holding group Successful Lotus. QuantumPharm (XtalPi) is founded by 3 MIT-trained (Massachusetts Institute of Technology) scientists Chairman Dr Wen Shuhao, CEO Dr Ma Jian and Chief Innnovation Officer Dr Lai Liping.

“ China Artificial Intelligence Drug Research Firm QuantumPharm XtalPi IPO in Hong Kong at $2.3 Billion Market Value & Raised $127 Million, IPO Price at HKD 5.28 with Share Price Increasing +9.8% to HKD 5.8 on Day 1 of Trading, First Hong Kong Exchange IPO under Chapter 18C Allowing IPO for Pre-Revenue Technology Firms with at Least HKD 10 Billion Market Value Equivalent to $1.2 Billion “

- Article continues below -

Sign Up
Basic Member: $5 Monthly | $60 Yearly
Newsletter Daily 2 pm (Promo): $20 Monthly | $180 Yearly (FP: $680)

The 2024 Investment Day
17th Oct Hong Kong | 7th Nov Singapore
Private Equity, Hedge Funds, Boutique Funds, Private Markets & more. Join 20+ CIOs & Senior investment team, with > 60% single family offices with $300 million AUM. Taking place on 17th Oct 2024 in Hong Kong, 7th Nov 2024 in Singapore. Every March, July, Sept, Oct & Nov.
Visit | Register here

The 2024 Family Office Summit
17th Oct Hong Kong St Regis | 7th Nov Singapore Amara Sanctuary Resort
Join 80 single family offices & family office professionals in Hong Kong & Singapore
Links: 2024 Family Office Summit | Register here

2024/2025 Institutional Investor Summit / Roundtable
March / Oct / Nov in Hong Kong & Singapore
Join CEOs, CIOs, Senior investment team from Sovereign Wealth Funds, Pension Funds, Endowments, Foundations & Charities in Hong Kong, Singapore & Asia-Pacific at the 2024 Institutional Investor Summit / Roundtable. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

2024/2025 Investment / Alternatives Summit
March / Oct / Nov in Hong Kong & Singapore
Join leading asset managers, hedge funds, boutique funds, private equity, venture capital & real estate firms in Hong Kong, Singapore & Asia-Pacific at the Investment / Alternatives Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

2024/2025 Private Wealth Summit
April / Oct / Nov in Hong Kong & Singapore
Join CEOs, CIOs, Head of Private Banking, Head of Family Offices & Product Heads at The Private Wealth Summit. Join as delegate, speaker, presenter, partner & sponsor.
Visit | Register here

China Artificial Intelligence Drug Research Firm QuantumPharm XtalPi to IPO in Hong Kong on 13th June 2024, Target to Raise $144 Million, First Hong Kong Exchange IPO under Chapter 18C Allowing IPO for Pre-Revenue Technology Firms with at Least HKD 10 Billion Market Value Equivalent to $1.2 Billion, Key Investors Include Tencent, HongShan, China Life Insurance, SoftBank & Google, IPO Cornerstone Investor Includes Chairman of Henderson Land Development Peter Lee Ka-kit Investment Holding Group Successful Lotus, QuantumPharm XtalPi Founded by 3 MIT-Trained Scientists Chairman Dr Wen Shuhao, CEO Dr Ma Jian & Chief Innnovation Officer Dr Lai Liping

7th June 2024 – China artificial intelligence (AI) drug research firm QuantumPharm (XtalPi) will IPO in Hong Kong (HKEX) on 13th June 2024, targeting to raise $144 million in the IPO. QuantumPharm XtalPi is the first Hong Kong Exchange IPO under the new Chapter 18C regime, allowing IPO for pre-revenue technology firms with at least HKD 10 billion market value ($1.2 billion). QuantumPharm (XtalPi) key investors include Tencent, HongShan, China Life Insurance, SoftBank & Google. QuantumPharm (XtalPi) IPO cornerstone investor includes Chairman of Henderson Land Development Peter Lee Ka-kit, via his investment holding group Successful Lotus. QuantumPharm (XtalPi) is founded by 3 MIT-trained (Massachusetts Institute of Technology) scientists Chairman Dr Wen Shuhao, CEO Dr Ma Jian and Chief Innnovation Officer Dr Lai Liping.

Managing $20 million to $3 billion. Investing $3 million to $300 million.
For Investment Managers, Hedge Funds, Boutique Funds, Private Equity, Venture Capital, Professional Investors, Family Offices, Private Bankers & Advisors, sign up today. Subscribe to Caproasia and receive the latest news, data, insights & reports, events & programs daily at 2 pm.

Join Events & Find Services
Join Investments, Private Wealth, Family Office events in Hong Kong, Singapore, Asia-wide. Find hard-to-find $3 million to $300 million financial & investment services at The Financial Centre | TFC. Find financial, investment, private wealth, family office, real estate, luxury investments, citizenship, law firms & more. List hard-to-find financial & private wealth services.

Have a product launch? Promote a product or service? List your service at The Financial Centre | TFC. Join interviews & editorial and be featured on Caproasia.com or join Investments, Private Wealth, Family Office events. Contact us at [email protected] or [email protected]

Caproasia.com | The leading source of data, research, information & resource for financial professionals, investment managers, professional investors, family offices & advisors to institutions, billionaires, UHNWs & HNWs. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?

Quick Links

2021 Data Release
2020 List of Private Banks in Hong Kong
2020 List of Private Banks in Singapore
2020 Top 10 Largest Family Office
2020 Top 10 Largest Multi-Family Offices
2020 Report: Hong Kong Private Banks & Asset Mgmt - $4.49 Trillion
2020 Report: Singapore Asset Mgmt - $3.48 Trillion AUM

For Investors | Professionals | Executives
Latest data, reports, insights, news, events & programs
Everyday at 2 pm
Direct to your inbox
Save 2 to 8 hours per week. Organised for success

Register Below

For CEOs, Heads, Senior Management, Market Heads, Desk Heads, Financial Professionals, Investment Managers, Asset Managers, Fund Managers, Hedge Funds, Boutique Funds, Analysts, Advisors, Wealth Managers, Private Bankers, Family Offices, Investment Bankers, Private Equity, Institutional Investors, Professional Investors

Get Ahead in 60 Seconds. Join 10,000 +
Save 2 to 8 hours weekly. Organised for Success.

Sign Up / Register

Web links may be disabled on mobile for security.
Please click on desktop.

New to Caproasia
Learn More | Sign Up | Subscribe | Register Events

Caproasia Users

Manage $20 million to $3 billion of assets
Invest $3 million to $300 million
Advise institutions, billionaires, UHNWs & HNWs

Caproasia Platforms | 11,000 Investors & Advisors

Monthly Roundtable & Networking

Family Office Programs

The 2024 Investment Day

March 2024 - Hong Kong
March 2024 - Singapore
July 2024 - Hong Kong
July 2024 - Singapore
Sept 2024 - Hong Kong
Sept 2024 - Singapore
Oct 2024 - Hong Kong
Nov 2024 - Singapore
Visit: The Investment Day | Register: Click here

Caproasia Summits

Contact Us

For Enquiries, Membership
[email protected], [email protected]

For Listing, Subscription
[email protected], [email protected]

For Press Release, send to:
[email protected]

For Events & Webinars
[email protected]

For Media Kit, Advertising, Sponsorships, Partnerships
[email protected]

For Research, Data, Surveys, Reports
[email protected]

For General Enquiries
[email protected]

Caproasia | Driving the future of Asia
a financial information technology co.
since 2014